Heparin-responsive angiopathy in the central nervous system caused by intravascular large B-cell lymphoma
暂无分享,去创建一个
H. Konno | Mika Watanabe | M. Tateyama | T. Akaishi | H. Kuroda | N. Fukuhara | S. Yoshida | M. Aoki
[1] L. Borsig,et al. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. , 2014, Thrombosis research.
[2] Kazuya Sato,et al. Prognostic impact of extranodal involvement in diffuse large B‐cell lymphoma in the rituximab era , 2012, Cancer.
[3] R. Zeisig,et al. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives. , 2012, Thrombosis research.
[4] L. Borsig,et al. Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins , 2012, International journal of cell biology.
[5] A. Khorana,et al. A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment , 2007, Cancer.
[6] D. Rontogianni,et al. Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy. , 2006, The oncologist.
[7] J. Berger,et al. Intravascular lymphomatosis presenting with sudden hearing loss , 2005, Journal of the Neurological Sciences.
[8] A. López-Guillermo,et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 , 2004, British journal of haematology.
[9] A. Patchefsky,et al. Case report 3 , 1976, Skeletal Radiology.
[10] T. Yoshino,et al. Intravascular lymphomatosis of the skin as a manifestation of recurrent B-cell lymphoma. , 2003, Journal of the American Academy of Dermatology.
[11] K. Ohshima,et al. Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies. , 1999, Leukemia & lymphoma.